/OSSFF
OSSFF Stock - Embla Medical hf.
Healthcare|Medical - DevicesOTC
$5.33+0.00%
+$0.00 (+0.00%) • Dec 19
76
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.88
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.99
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $5.86
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OSSFF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$5.27 – $5.38
TARGET (TP)$6.12
STOP LOSS$4.90
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.53
52W High$5.33
52W Low$4.08
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $854.89M | $785.68M | $718.65M | $718.67M | $629.50M |
| Gross Profit | $500.25M | $454.39M | $407.94M | $421.07M | $360.56M |
| Gross Margin | 58.5% | 57.8% | 56.8% | 58.6% | 57.3% |
| Operating Income | $112.75M | $87.46M | $85.14M | $95.62M | $54.07M |
| Net Income | $68.28M | $58.39M | $42.51M | $63.99M | $6.21M |
| Net Margin | 8.0% | 7.4% | 5.9% | 8.9% | 1.0% |
| EPS | $0.16 | $0.14 | $0.10 | $0.15 | $0.01 |
Company Overview
Embla Medical hf is a global orthopaedics company, which engages in the design, development, manufacture, and sale of non-invasive orthopedic products. It operates through the following geographical segments: Americas; Europe Middle-East and Africa; and Americas and Aisa-Pacific. The company was founded by Össur Kristinsson in 1971 and is headquartered in Reykjavík, Iceland.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
OSSFFBeat Rate
42%
Last 19 quarters
Avg Surprise
-3.0%
EPS vs Estimate
Beats / Misses
8/9
2 met exactly
Latest EPS
$0.06
Q4 2025
EPS Surprise History
Q1 24
+5.9%
$0.05vs$0.04
Q2 24
-26.9%
$0.02vs$0.03
Q3 24
+1.5%
$0.05vs$0.05
Q4 24
+23.4%
$0.05vs$0.04
Q1 25
-9.3%
$0.04vs$0.05
Q2 25
-19.5%
$0.03vs$0.04
Q3 25
+0.5%
$0.05vs$0.05
Q4 25
+8.7%
$0.06vs$0.06
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 3, 2026 | — | — | — | — |
Q4 2025 | Oct 31, 2025 | $0.06 | $0.06 | +8.7% | ✓ BEAT |
Q3 2025 | Jul 22, 2025 | $0.05 | $0.05 | +0.5% | ✓ BEAT |
Q2 2025 | Apr 29, 2025 | $0.04 | $0.03 | -19.5% | ✗ MISS |
Q1 2025 | Feb 5, 2025 | $0.05 | $0.04 | -9.3% | ✗ MISS |
Q4 2024 | Oct 22, 2024 | $0.04 | $0.05 | +23.4% | ✓ BEAT |
Q3 2024 | Jul 23, 2024 | $0.05 | $0.05 | +1.5% | ✓ BEAT |
Q2 2024 | Apr 23, 2024 | $0.03 | $0.02 | -26.9% | ✗ MISS |
Q1 2024 | Mar 13, 2024 | $0.04 | $0.05 | +5.9% | ✓ BEAT |
Q3 2023 | Sep 30, 2023 | $0.02 | $0.03 | +33.6% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.03 | $0.04 | +10.4% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $0.03 | $0.02 | -11.1% | ✗ MISS |
Q1 2023 | Jan 31, 2023 | $0.04 | $0.03 | -25.0% | ✗ MISS |
Q4 2022 | Oct 25, 2022 | $0.03 | $0.02 | -20.0% | ✗ MISS |
Q3 2022 | Jul 21, 2022 | $0.05 | $0.03 | -40.0% | ✗ MISS |
Q2 2022 | Apr 26, 2022 | $0.02 | $0.02 | 0.0% | = MET |
Q1 2022 | Feb 1, 2022 | $0.05 | $0.04 | -20.0% | ✗ MISS |
Q4 2021 | Oct 26, 2021 | $0.05 | $0.04 | -20.0% | ✗ MISS |
Q3 2021 | Jul 22, 2021 | $0.05 | $0.05 | 0.0% | = MET |
Q2 2021 | Apr 27, 2021 | $0.02 | $0.03 | +50.0% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about OSSFF
What is OSSFF's current stock price?
Embla Medical hf. (OSSFF) is currently trading at $5.33 per share. The stock has moved +0.00% today.
What is the analyst price target for OSSFF?
No analyst price targets are currently available for this stock.
What sector is Embla Medical hf. in?
Embla Medical hf. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is OSSFF's market cap?
Embla Medical hf. has a market capitalization of $2.27 billion, making it a mid-cap company.
Does OSSFF pay dividends?
No, Embla Medical hf. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALFRY
Alfresa Holdings Corporation
$15.14
Mkt Cap: $2.8B
DMPHF
Dermapharm Holding SE
$39.56
Mkt Cap: $2.1B
GGNDF
GN Store Nord A/S
$16.62
Mkt Cap: $2.4B
GNNDY
GN Store Nord A/S
$48.82
Mkt Cap: $2.4B
HBMHF
HBM Holdings Limited
$2.52
Mkt Cap: $2.1B
MEDGF
Medacta Group S.A.
$83.91
Mkt Cap: $1.7B
SHPHF
Sihuan Pharmaceutical Holdings Group Ltd.
$0.16
Mkt Cap: $1.5B
STSEY
Stratec SE
$5.10
Mkt Cap: $1.5B
TCGGY
Tecan Group AG
$36.00
Mkt Cap: $2.3B
VTRLY
Vitrolife AB (publ)
$15.06
Mkt Cap: $2.0B
Explore stocks similar to OSSFF for comparison